MDT

89.97

+2.2%↑

MDT

89.97

+2.2%↑

MDT

89.97

+2.2%↑

MDT

89.97

+2.2%↑

MDT

89.97

+2.2%↑

Search

Glaukos Corp

Abierto

Sector Salud

128.91 -18.74

Resumen

Variación precio

24h

Actual

Mínimo

127.46

Máximo

158.88

Métricas clave

By Trading Economics

Ingresos

29M

-21M

Ventas

980K

97M

BPA

-0.28

Margen de beneficio

-22.146

Empleados

907

EBITDA

19M

-11M

Recomendaciones

By TipRanks

Recomendaciones

Compra Fuerte

Estimación a 12 meses

+6.13 upside

Dividendos

By Dow Jones

Próximas Ganancias

30 abr 2025

Estadísticas de Mercado

By TradingEconomics

Capitalización de Mercado

8.9B

Apertura anterior

147.65

Cierre anterior

128.91

Noticias sobre sentimiento de mercado

By Acuity

19%

81%

41 / 393 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Bullish Evidence

Glaukos Corp Gráfico

El rendimiento pasado no es un indicador fiable de resultados futuros.

Noticias Relacionadas

20 feb 2025, 22:11 UTC

Ganancias

Booking Holdings 4Q Earnings Top Expectations

20 feb 2025, 21:19 UTC

Ganancias

QBE Insurance Lifts Dividend as Annual Profit Rises 27% -- Update

20 feb 2025, 21:06 UTC

Ganancias

QBE Insurance Lifts Dividend as Annual Profit Rises 27%

20 feb 2025, 23:48 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

20 feb 2025, 23:48 UTC

Charlas de Mercado

Nikkei May Fall Amid Concerns About Borrowing Costs -- Market Talk

20 feb 2025, 22:21 UTC

Ganancias

Amazon Takes Walmart's Revenue Crown (For Now) -- IBD

20 feb 2025, 22:20 UTC

Ganancias

Wayfair Stock Rebounds as Outlook Offsets Hefty Loss -- Barrons.com

20 feb 2025, 22:04 UTC

Ganancias

Eldorado Gold 4Q Adj EPS 62c >EGO

20 feb 2025, 22:04 UTC

Ganancias

Eldorado Gold 4Q Rev $435.7M >EGO

20 feb 2025, 21:55 UTC

Ganancias
Adquisiciones, fusiones, absorciones

Celsius Shares Soared on Earnings Beat and Alani Nu Acquisition -- Barrons.com

20 feb 2025, 21:50 UTC

Charlas de Mercado

Financial Services Roundup: Market Talk

20 feb 2025, 21:50 UTC

Charlas de Mercado
Adquisiciones, fusiones, absorciones

Health Care Roundup: Market Talk

20 feb 2025, 21:50 UTC

Charlas de Mercado
Ganancias

Auto & Transport Roundup: Market Talk

20 feb 2025, 21:31 UTC

Ganancias

Nu Holdings 4Q Net $552.6M >NU

20 feb 2025, 21:31 UTC

Ganancias

Nu Holdings 4Q Rev $2.99B >NU

20 feb 2025, 21:31 UTC

Ganancias

Alibaba Stock Jumps Following Earnings Beat, Strong AI Cloud Growth -- IBD

20 feb 2025, 21:30 UTC

Ganancias

Nu Holdings Had Total of 114.2 M Customers Globally by Dec 31 >NU

20 feb 2025, 21:29 UTC

Ganancias

Nu Holdings Added 4.5 M Customers in 4Q >NU

20 feb 2025, 21:25 UTC

Principales Noticias

Dow, S&P 500 Fall; Walmart Stock Drops -- WSJ

20 feb 2025, 21:21 UTC

Ganancias

Mercedes-Benz Earnings Are a Bad Sign for EV Sales. What It Means for Ford, Tesla. -- Barrons.com

20 feb 2025, 21:19 UTC

Ganancias

Century Aluminum Adjuted EBITDA View Based on Improved Metal Pricing, Regional Premiums Offset by Higher Energy,Raw Material Costs >CENX

20 feb 2025, 21:18 UTC

Ganancias

Century Aluminum Sees 1Q Adjusted EBITDA $75M to $85 M >CENX

20 feb 2025, 21:18 UTC

Charlas de Mercado

Gold Pushes to Another New Record -- Market Talk

20 feb 2025, 21:16 UTC

Ganancias

These Stocks Moved the Most Today: Carvana, Vimeo, Alibaba, Wayfair, Palantir, D-Wave Quantum, and More -- Barrons.com

20 feb 2025, 21:15 UTC

Principales Noticias

IRS Begins to Fire 6,000 Workers, Threatening Tax-Season Delays -- WSJ

20 feb 2025, 21:07 UTC

Ganancias

Newmont: Gold Prices Predicted to Remain Strong >NEM

20 feb 2025, 21:06 UTC

Ganancias

Newmont 4Q Cont Ops EPS $1.24 >NEM

20 feb 2025, 21:06 UTC

Ganancias

Newmont 4Q Sales $5.65B >NEM

20 feb 2025, 21:06 UTC

Ganancias

Newmont 4Q Adj EPS $1.40 >NEM

20 feb 2025, 21:06 UTC

Ganancias

Booking Holdings: In Jan., Board Authorized Program to Repurchase Up to Additional $20B in Stock

Comparación entre iguales

Cambio de precio

Glaukos Corp Esperado

Precio Objetivo

By TipRanks

6.13% repunte

Estimación a 12 meses

Media 167 USD  6.13%

Máximo 200 USD

Mínimo 120 USD

De acuerdo con 12 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Glaukos Corp Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

12 ratings

11

Comprar

0

Mantener

1

Vender

Puntuación técnica

By Trading Central

153.81 / 160.58Soporte y Resistencia

Corto Plazo

Bullish Evidence

Medio plazo

Weak Bearish Evidence

Largo Plazo

Weak Bullish Evidence

Sentimiento

By Acuity

41 / 393 Clasificación en Salud

Noticias sobre sentimiento de mercado

Coyuntura alcista notoria

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por encima de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Glaukos Corp

Glaukos Corporation, an ophthalmic pharmaceutical and medical technology company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent and iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-to-moderate open-angle glaucoma. The company's product pipeline includes iStent Infinite indicated for use in the treatment of patients with glaucoma uncontrolled by prior medical and surgical therapy; and iDose TR, an intracameral procedural pharmaceutical therapy indicated for the reduction of intraocular pressure in patients with open-angle glaucoma or ocular hypertension. The company markets its products through direct sales organization, as well as through distributors in the United States and internationally. Glaukos Corporation was incorporated in 1998 and is headquartered in Aliso Viejo, California.